Cancer of Unknown Primary (CUP)
- the fourth most common cause of cancer mortality

• Save valuable time when it counts
  • Reduce the expense and emotional turmoil of extensive diagnostic procedures
• Speed up diagnosis
  • Confidently identify the tumor of origin in patients presenting with metastatic cancer
  • Receive conclusive answers in up to 90 % of all cases within 10 working days.
• Optimize patient management through improved treatment guided by tumor type specific therapy
• Improve treatment response and overall prognosis

Studies show that survival duration of patients in whom the primary tumor was diagnosed was superior to that of patients in whom the primary tumor remained unknown (Abbruzzese et al, (1995) J. Clin Oncol.13; 2094-2103). By identifying the site of the primary tumor, CupPrint provides physicians with a unique opportunity to ensure the most effective treatment regime, while taking advantage of the latest developments in cancer diagnostics. CupPrint simultaneously and accurately measures the expression of hundreds of class-discriminating genes in a small representative sample of the metastasis, leveraging knowledge about the differences between cancer types at the molecular level. CupPrint can identify the primary site of many different types of carcinomas (epithelial malignancies) as well as other types of cancer such as sarcoma and melanoma.

Download brochures